NHS Partnerships and Collaborations

Collaborative Working (including Joint Working) 

  • Boehringer Ingelheim is committed to working in partnership with the NHS through the ABPI Collaborative Working framework to implement sustainable healthcare projects which benefit patient outcomes and/or the NHS.
  • Collaborative working projects require the ‘pooling of resources’ and a contractual arrangement between the NHS organisation and Boehringer Ingelheim, and as such a detailed scoping and governance process is followed.  For further information see Joint Working - a toolkit for industry and the NHS | ABPI
  • For further information regarding Collaborative Working please contact the Boehringer Ingelheim Partnerships Team at hphealthcarepartnerships.gb@boehringer-ingelheim.com 

The Provision of Support for Investigator-led Clinical Research

Investigator Initiated Studies (IIS)

  • Boehringer Ingelheim supports academic and community based researchers or consortia who are interested in independently proposing and conducting their own clinical research. Boehringer lngelheim may provide financial support and/or drug for approved IIS
  • Boehringer lngelheim does not serve as the regulatory sponsor for IIS
  • In general, IIS are not registrational studies and may be proof of concept or exploratory in nature. The budget for such studies should reflect fair market value for all costs
  • Boehringer lngelheim requires researchers to apply for funding via an online application process
For further information and to submit an application please click here to access the Funding Portal 

The Provision of Support to Healthcare Organisations, Healthcare Professionals and Patient Organisations

Boehringer Ingelheim (BIL) is committed to enhancing patient care in the UK by considering requests for support through:
  • Donations and Grants (DAG) (donations, grants & benefits in kind)) to Healthcare Organisations and Independent Medical Education Organisations
  • Financial support (grants) for independent educational meetings organised by Healthcare Organisations (or a 3rd party), where Boehringer Ingelheim is not purchasing a commercial opportunity such as a promotional stand
  • Financial support (grants) to Patient Organisations to aid with disease awareness projects or activities 
  • Boehringer Ingelheim requires HCOs/IME and Patient Organisations to apply for funding via an online application process
At the current time, Boehringer Ingelheim is only able to consider requests within the following therapy areas:
  • Respiratory including Specialty Lung Diseases 
  • Oncology 
  • Cardiovascular, renal and metabolic diseases
If your request for support is related to the impact of COVID-19, we continue to welcome requests but please consider and explain the impact of the COVID-19 situation on the merits of your application at this time and specifically, the timelines. 
 
Please download the COVID-19 questionnaire here and attach this document to your online application form, after registering your details to apply for a MEGS using the Funding Portal.
 
For further information and to submit an application please click here to access the Funding Portal 
 
Each request must:
  • Be submitted at least 8 weeks in advance of the proposed activity taking place. Due to administrative restrictions, BIL may not consider requests within a shorter timeline
  • Stipulate how the support will benefit patient care and / or the NHS 
  • Include all relevant key information about the proposed activity or educational meeting e.g. agenda
  • Provide a breakdown of the overall costs for the proposed activity or educational meeting
  • Specify the total amount of funding being requested and if any other funding contributions have been sought

Please note: ALL qualifying applications are reviewed by the Boehringer Ingelheim Funding Governance Committee. No commitment of support can be made prior to committee approval. Successful applications for funding will be subject to public disclosure as a Transfer of Value to a Healthcare or Patient Organisation in accordance with the ABPI Code of Practice.

Any provision of support by Boehringer Ingelheim is by no means intended to impose undue influence or induce the prescription, administration, recommendation, purchase or sale of any Boehringer Ingelheim medicines. 

Boehringer Ingelheim UK cannot support requests for:

  • Funding to individual Healthcare Professionals, e.g. support for personal development opportunities, individual research projects or academic qualifications (e.g. MSc, PhD)
  • Requests from Healthcare Professionals for support towards attendance at professional and scientific conferences
  • Purchase of day-to-day equipment
  • Religious programmes
  • Financial contributions to Political Parties
  • Charitable fundraising events outside the UK
  • Social events
If you have any questions regarding the process, please contact us via ethicsandcompliance.bra@boehringer-ingelheim.com
 
BIL will keep a record of your name, email address, organisation address and any other relevant information that you provide for as long as required to process your application and meet financial, legal and transparency obligations. Only BIL will use data for the purpose of evaluating the application and, if successful, processing and managing the support. For more information on your rights to access this data and how we process personal information, please see our Privacy Policy. Thank you.
 
 

NP-GB-102361 | September 2021